-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $255

Benzinga·04/24/2025 18:27:12
Listen to the news
RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $247 to $255.